Clonal expansion of CD8+ effector T cells in patients with calcific aortic valve disease

Clicks: 11
ID: 333507
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #147 of 164 articles by views in cardiovascular research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 164 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Aims Calcific aortic valve disease (CAVD) is a complex cardiovascular pathology, culminating in aortic stenosis and heart failure with no effective treatment strategy, except invasive surgery. While inflammation may contribute to valvular fibro-calcific pathology and T cells have been identified within the leaflets, their contribution to CAVD pathogenesis remains unclear. Methods & Results Disease-staged whole-tissue proteomics (n=16) confirmed a pro-inflammatory T cell driven signature, with immunohistochemistry (n=10) and immunofluorescence (n=8) conducted on control and CAVD valves to confirm T cell localization to calcified regions. Flow cytometry immunophenotyping (n=20) was was performed using valvular tissue and corresponding peripheral blood from the same individuals. Single cell RNA sequencing and paired single T cell receptor sequencing was conducted on an additional 4 patients on CD45+, CD3+, CD4+ or CD8+ T cells. T cell signaling was identified through unsupervised clustering. Tissue resident memory (TRM) T cells were detected within the valve, exhibiting a highly cytotoxic, activated, and terminally differentiated phenotype. This pan-pro-inflammatory signal was differentially identified in T cells originating from the valve tissue, and not observed in the blood, indicative of an adaptive, local and non-systemic inflammatory signature in CAVD patients. T cell receptor analysis detected hyperexpanded clones within the CD8+ T cell central memory (TCM) population, with TRM cells comprising most of the large and medium clonal expansion within the T cell population. Clonal expansion was more prominent in valve tissue, with expanded clones largely confined to their tissue of origin. Clonal interaction network analysis demonstrated the greatest proportion of clones originating from CD8+ TCM and TRM populations, exhibiting a tissue resident, cytotoxic environment within the valve. Conclusions Taken together, the data define distinct T cell subpopulations in CAVD and implicate specific antigenic epitopes driving clonal expansion of valvular T cells, supporting a central role for antigen-driven, autoimmune-like inflammation in disease propagation.
Reference Key
openalex_W7223211259 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Francesca Bartoli‐Leonard, Sarvesh Chelvanambi, Tan Pham, Cassandra L. Clift, Mandy E. Turner, Mark Blaser, Sasha A. Singh, Massimo Caputo, Masanori Aikawa, Amanda Y. Pang, Jochen Daniel Muehlschlegel, Elena Rabkin Aikawa
Are you one of these authors? Claim your profile
Journal cardiovascular research
Year 2026
DOI
10.1093/cvr/cvag238
URL
https://doi.org/10.1093/cvr/cvag238
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.